「per」の検索結果
51件：11～15件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
ent principle. To do this, we engage in “if I were you” - the company concept that helps us see the perspective of others.Changes in the environment of our society and medical care occur with increasi...
http://www.senju.co.jp/english/about/message.html -
Publications | Research & Development | SENJU Pharmaceutica
lar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japan Yasuo Yanagi1, Kanji Takahashi2, Tomohiro Iida3, Fumi Gomi4, Hiroshi Onishi5, ...
http://www.senju.co.jp/english/rd/thesis/ -
leate, hereinafter referred to as “the new formulation”) for the treatment of glaucoma and ocular hypertension. Pharmaceutical information activities for this product will be conducted jointly by Senj...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
「If I were you」に基づく研究開発 点眼剤の製剤開発と創意工夫 | SENJU SENSE | 千寿製薬について | 千寿製薬株式会社
ノズルの形状を改良して点眼しやすくするといった「製剤開発でできること」によって、患者さんのQOL**向上に少しでも貢献することが私たちの使命です。 * Kashiwagi K., Furuya T. Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Japanese Journal ...
https://www.senju.co.jp/about/senjusense/senjusense04.html -
leate, hereinafter referred to as “the new formulation”) for the treatment of glaucoma and ocular hypertension. Pharmaceutical information activities for this product will be conducted jointly by Senj...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf